As filed with the Securities and Exchange Commission on March 6, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Generation Bio Co.
(Exact Name of Registrant as Specified in Its Charter)
Delaware | | 81-4301284 |
(State or Other Jurisdiction of Incorporation or Organization) | | (I.R.S. Employer Identification No.) |
301 Binney Street Cambridge, Massachusetts | | 02142 |
(Address of Principal Executive Offices) | | (Zip Code) |
2020 Stock Incentive Plan
2020 Employee Stock Purchase Plan
(Full Title of the Plan)
Geoff McDonough, M.D.
President and Chief Executive Officer
301 Binney Street
Cambridge, MA 02142
(Name and Address of Agent for Service)
(617) 655-6500
(Telephone Number, Including Area Code, of Agent for Service)
Copies to:
Yalonda Howze
Chief Legal Officer
301 Binney Street
Cambridge, MA 02142
(617) 655-6500
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | |
Large accelerated filer | ☐ | | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | | Smaller reporting company | ☒ |
| | | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐